paclitaxel has been researched along with Hyperbilirubinemia, Hereditary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argon, A; Aydiner, A; Saip, P; Tas, F; Topuz, E | 1 |
1 other study(ies) available for paclitaxel and Hyperbilirubinemia, Hereditary
| Article | Year |
|---|---|
Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hyperbilirubinemia; Hyperbilirubinemia, Hereditary; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2002 |